• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟发性庞贝病在未分类的肢带型肌营养不良症中较为常见。

Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies.

机构信息

Neuromuscular Research Unit, Department of Neurology, University of Copenhagen, Copenhagen, Denmark.

出版信息

Mol Genet Metab. 2013 Nov;110(3):287-9. doi: 10.1016/j.ymgme.2013.08.005. Epub 2013 Aug 15.

DOI:10.1016/j.ymgme.2013.08.005
PMID:24011652
Abstract

OBJECTIVE

Late-onset Pompe disease is a rare, but potentially treatable metabolic myopathy, and therefore should not be overlooked. However, it is not unusual that patients go undiagnosed for many years. We hypothesized that patients with late-onset Pompe disease may have been overlooked in a population of patients with unclassified neuromuscular disease.

METHODS

We used DBS (dried blood spots) to screen for Pompe disease in the two largest neuromuscular clinics and one of the main respiratory centers in Denmark. We selected patients with unclassified LGDM (limb-girdle muscular dystrophy), idiopathic elevation of creatine kinase, unexplained myopathy on muscle biopsy, unexplained restrictive respiratory insufficiency or unspecified myopathy for screening.

RESULTS

177 patients were found eligible for inclusion, and 103 (58.2%) patients accepted screening. Three patients with Pompe disease were identified with DBS, and subsequent genetic testing revealed known pathogenic mutations in the GAA gene. All three patients were found among 38 patients with unclassified LGMD (8%).

CONCLUSION

Our findings indicate that a DBS should be considered early in the diagnostic work-up of patients with an LGMD phenotype, to rule out Pompe disease. Retrospectively, all 3 patients presented with "red flags" more compatible with Pompe disease than LGMD, including; 1) mild non-dystrophic, myopathic features on muscle biopsy, 2) creatine kinase levels below 1000, and 3) disproportionate axial and respiratory muscle involvement in comparison with limb muscle involvement.

摘要

目的

迟发性庞贝病是一种罕见但有潜在治疗效果的代谢性肌病,因此不应被忽视。然而,患者多年未被诊断的情况并不少见。我们假设在未分类的神经肌肉疾病患者人群中,可能忽略了迟发性庞贝病患者。

方法

我们使用 DBS(干血斑)在丹麦最大的两个神经肌肉诊所和一个主要呼吸中心筛查庞贝病。我们选择未分类的 LGMD(肢带型肌营养不良症)、肌酸激酶升高、肌肉活检不明原因肌病、不明原因的限制性呼吸不足或未明确肌病的患者进行筛查。

结果

发现 177 名患者符合纳入标准,其中 103 名(58.2%)患者接受了筛查。通过 DBS 发现了 3 名庞贝病患者,随后的基因检测显示 GAA 基因存在已知的致病性突变。这 3 名患者均在 38 名未分类的 LGMD 患者(8%)中发现。

结论

我们的研究结果表明,在具有 LGMD 表型的患者的诊断工作中,应早期考虑进行 DBS,以排除庞贝病。回顾性分析,所有 3 名患者均表现出与 LGMD 相比更符合庞贝病的“危险信号”,包括:1)肌肉活检显示轻微的非营养不良性、肌病特征,2)肌酸激酶水平低于 1000,3)与肢体肌肉受累相比,轴向和呼吸肌受累不成比例。

相似文献

1
Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies.迟发性庞贝病在未分类的肢带型肌营养不良症中较为常见。
Mol Genet Metab. 2013 Nov;110(3):287-9. doi: 10.1016/j.ymgme.2013.08.005. Epub 2013 Aug 15.
2
Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: A Spanish cohort.使用干血对未分类的肢带型肌营养不良或无症状高肌酸激酶血症患者进行庞贝病检测的靶向筛查:一项西班牙队列研究。
Neuromuscul Disord. 2015 Jul;25(7):548-53. doi: 10.1016/j.nmd.2015.04.008. Epub 2015 Apr 23.
3
The frequency of late-onset Pompe disease in pediatric patients with limb-girdle muscle weakness and nonspecific hyperCKemia: A multicenter study.肢带型肌无力和非特异性高肌酸激酶血症的儿科患者中晚发型庞贝病的发病率:一项多中心研究。
Neuromuscul Disord. 2016 Nov;26(11):796-800. doi: 10.1016/j.nmd.2016.09.001. Epub 2016 Sep 6.
4
Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness.3076例高肌酸激酶血症和肢带型肌无力患者中庞贝病的患病率
Neurology. 2016 Jul 19;87(3):295-8. doi: 10.1212/WNL.0000000000002758. Epub 2016 May 11.
5
Late-onset Pompe disease: what is the prevalence of limb-girdle muscular weakness presentation?晚发型庞贝病:肢带型肌无力表现的患病率是多少?
Arq Neuropsiquiatr. 2018 Apr;76(4):247-251. doi: 10.1590/0004-282x20180018.
6
Next generation sequencing detection of late onset pompe disease.晚发型庞贝病的下一代测序检测
Muscle Nerve. 2016 Jun;53(6):981-3. doi: 10.1002/mus.25042. Epub 2016 Apr 25.
7
Identification of GAA variants through whole exome sequencing targeted to a cohort of 606 patients with unexplained limb-girdle muscle weakness.通过外显子组测序鉴定 606 例不明原因肢带肌无力患者的 GAA 变异体。
Orphanet J Rare Dis. 2017 Nov 17;12(1):173. doi: 10.1186/s13023-017-0722-1.
8
[A retrospective study of six patients with late-onset Pompe disease].六例晚发型庞贝病患者的回顾性研究
Rev Neurol (Paris). 2008 Apr;164(4):336-42. doi: 10.1016/j.neurol.2007.09.008.
9
Diagnostic criteria for late-onset (childhood and adult) Pompe disease.晚发型(儿童及成人型)庞贝病的诊断标准。
Muscle Nerve. 2009 Jul;40(1):149-60. doi: 10.1002/mus.21393.
10
Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and/or hyperCKemia.不明原因肌病和/或高肌酸激酶血症患者迟发性庞贝病的延迟诊断。
Mol Genet Metab. 2015 Apr;114(4):580-3. doi: 10.1016/j.ymgme.2015.02.004. Epub 2015 Feb 21.

引用本文的文献

1
A study to identify individuals at risk to be affected by late-onset Pompe disease who had previously been given a non-specific or tentative diagnosis for their muscle weakness (Pompe PURSUE).一项旨在识别曾因肌肉无力被给予非特异性或初步诊断、有患晚发性庞贝病风险个体的研究(庞贝病追踪研究)。
Orphanet J Rare Dis. 2025 Jan 14;20(1):23. doi: 10.1186/s13023-024-03425-1.
2
The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II).欧洲代谢疾病参考网络(MetabERN)对庞贝病(酸性麦芽糖酶缺乏症,糖原贮积症 II 型)的临床路径建议。
Orphanet J Rare Dis. 2024 Nov 1;19(1):408. doi: 10.1186/s13023-024-03373-w.
3
Non-invasive optoacoustic imaging of glycogen-storage and muscle degeneration in late-onset Pompe disease.
应用无创光声成像技术对晚发性庞贝氏病的肝糖存储和肌肉退化进行检测。
Nat Commun. 2024 Sep 8;15(1):7843. doi: 10.1038/s41467-024-52143-6.
4
Diagnostic delay in late-onset Pompe disease among Chinese patients: A retrospective study.中国患者晚发型庞贝病的诊断延迟:一项回顾性研究。
JIMD Rep. 2023 Dec 20;65(1):39-46. doi: 10.1002/jmd2.12404. eCollection 2024 Jan.
5
Screening for late-onset Pompe disease in Internal Medicine departments in Spain.在西班牙的内科部门进行晚期庞贝病的筛查。
Orphanet J Rare Dis. 2023 Aug 31;18(1):256. doi: 10.1186/s13023-023-02887-z.
6
Expert opinion on the diagnostic odyssey and management of late-onset Pompe disease: a neurologist's perspective.迟发性庞贝病诊断历程与管理的专家意见:一位神经科医生的观点
Front Neurol. 2023 May 17;14:1095134. doi: 10.3389/fneur.2023.1095134. eCollection 2023.
7
Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices: The IPaNeMA Study.调查神经肌肉医学学术实践中晚发型庞贝病的患病率:IPaNeMA研究。
Neurol Genet. 2021 Oct 18;7(6):e623. doi: 10.1212/NXG.0000000000000623. eCollection 2021 Dec.
8
Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation.晚期晚发型庞贝病5年酶替代疗法的益处。一例误诊三十年、初诊时伴有急性呼吸衰竭的病例报告。
Mol Genet Metab Rep. 2022 Jul 18;32:100896. doi: 10.1016/j.ymgmr.2022.100896. eCollection 2022 Sep.
9
Molecular Diagnosis of Pompe Disease in the Genomic Era: Correlation with Acid Alpha-Glucosidase Activity in Dried Blood Spots.基因组时代庞贝病的分子诊断:与干血斑中酸性α-葡萄糖苷酶活性的相关性
J Clin Med. 2021 Aug 28;10(17):3868. doi: 10.3390/jcm10173868.
10
Genotype-phenotype correlation of 17 cases of Pompe disease in Spanish patients and identification of 4 novel GAA variants.17 例西班牙庞贝病患者的基因型-表型相关性及 4 种新 GAA 变异的鉴定。
Orphanet J Rare Dis. 2021 May 21;16(1):233. doi: 10.1186/s13023-021-01864-8.